Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minn.
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Minnesota, Minneapolis, Minn.
Transl Res. 2014 Nov;164(5):359-65. doi: 10.1016/j.trsl.2014.05.011. Epub 2014 May 24.
Tunneling nanotubes (TnTs) represent a novel mechanism by which intercellular components such as proteins, Golgi vesicles, and mitochondria can be transferred from cell to cell in the complex tumor microenvironment. Here, we report data showing that microRNAs (miRNAs) are transferred through TnTs in osteosarcoma (OS) and ovarian cancer as in vitro model systems. miRNA array analysis demonstrated significant upregulation of miR-19a in OS tumors resected from human patients, and differential expression of miR-199a in ovarian cancer cell lines resistant or sensitive to platinum chemotherapy. K7M2 murine OS cells were transfected with miR-19a and cultured with nontransfected K7M2 cells in low-serum, hyperglycemic medium for up to 72 hours to induce TnT formation. miRNA transfer via TnTs was detected by time-lapse microscopic imaging. miR-19a was also transported via TnTs connecting transfected K7M2 cells and nontransfected stromal MC3T3 murine osteoblast cells. Similar findings were observed in studies of TnT-mediated transport of miR-199a among SKOV3 ovarian cancer cells and nonmalignant immortalized ovarian epithelial cells. To quantify TnT-mediated transport of miRNAs, we used modified Boyden chambers to separate miR-19a-transfected K7M2 cells (top chamber) and DiI-labeled MC3T3 cells (bottom chamber) compared with open culture of these cells. Fluorescence-activated cell sorting analysis of cells collected after 48 hours of culture indicated that miR-19a-positive MC3T3 cells were 3-fold higher in open culture; this finding suggests that miR-19a transfer occurred via TnTs, exclusive of other forms of cell-cell communication. These studies demonstrate that TnTs mediate direct transfer of genetic material between tumor and stromal cells.
隧道纳米管 (TnTs) 代表了一种新的机制,通过该机制,蛋白质、高尔基小泡和线粒体等细胞内成分可以在复杂的肿瘤微环境中从一个细胞传递到另一个细胞。在这里,我们报告的数据显示,微小 RNA (miRNA) 可以通过隧道纳米管在骨肉瘤 (OS) 和卵巢癌中传递,作为体外模型系统。miRNA 阵列分析表明,在从人类患者切除的 OS 肿瘤中,miR-19a 显著上调,并且在对铂类化疗敏感或耐药的卵巢癌细胞系中,miR-199a 表达差异。将 miR-19a 转染 K7M2 鼠骨肉瘤细胞,并在低血清、高糖培养基中与未转染的 K7M2 细胞共培养长达 72 小时,以诱导 TnT 形成。通过时差显微镜成像检测 TnT 介导的 miRNA 转移。miR-19a 也通过连接转染的 K7M2 细胞和未转染的基质 MC3T3 鼠成骨细胞的 TnT 进行运输。在 SKOV3 卵巢癌细胞和非恶性永生化卵巢上皮细胞中 TnT 介导的 miR-199a 转运研究中观察到类似的发现。为了定量 TnT 介导的 miRNA 转运,我们使用改良的 Boyden 室将 miR-19a 转染的 K7M2 细胞(上室)和 DiI 标记的 MC3T3 细胞(下室)分开,与这些细胞的开放培养进行比较。培养 48 小时后收集的细胞的荧光激活细胞分选分析表明,在开放培养中,miR-19a 阳性的 MC3T3 细胞增加了 3 倍;这一发现表明 miR-19a 的转移是通过 TnTs 发生的,而不是其他形式的细胞间通讯。这些研究表明,隧道纳米管介导肿瘤细胞和基质细胞之间遗传物质的直接转移。